Free Trial
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

ARK Genomic Revolution ETF logo
$26.93 +3.32 (+14.06%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$26.96 +0.03 (+0.10%)
As of 02/21/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ARK Genomic Revolution ETF (BATS:ARKG)

Key Stats

Today's Range
$24.20
$25.24
50-Day Range
$22.90
$29.79
52-Week Range
N/A
Volume
4.90 million shs
Average Volume
N/A
Market Capitalization
$1.52 billion
Assets Under Management
$1.26 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.56%0.57%0.53%
Other Expenses0.00%0.57%0.50%0.45%0.53%
Total Expense0.75%0.72%0.72%0.69%0.71%
Fee Waiver0.00%-0.72%-0.50%-0.34%-0.56%
Net Expense0.75%0.60%0.62%0.64%0.60%
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

ARKG ETF News Headlines

ARK Invest Europe Prepares to Close Rize Digital Payments ETF
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
Unusually active option classes on open February 18th
See More Headlines

ARKG ETF - Frequently Asked Questions

ARK Genomic Revolution ETF's stock was trading at $23.5450 at the start of the year. Since then, ARKG stock has increased by 14.4% and is now trading at $26.9290.
View the best growth stocks for 2025 here
.

Top institutional investors of ARK Genomic Revolution ETF include JPMorgan Chase & Co. (4.94%), IMC Chicago LLC, Two Sigma Investments LP (1.70%) and LPL Financial LLC (1.22%).

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), ARK Innovation ETF (ARKK), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL).

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
41

Fund Statistics

Assets Under Management
$1.26 billion
Average Daily Volume
$3.41 million
Discount/Premium
0.36%

Administrator, Advisor and Custodian

Administrator
The Bank of NewYork Mellon Corporation
Advisor
ARK Investment Management LLC
Custodian
The Bank of NewYork Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of NewYork Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
37,350
Put Options
20,719
Call Options
16,631

Miscellaneous

Beta
1.99
Creation Unit
50,000
Creation Fee
$500.00
10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure


This page (BATS:ARKG) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners